Abstract:Drug repurposing has broad importance in planetary health for therapeutics innovation in infectious diseases as well as common or rare chronic human diseases. Drug repurposing has also proved important to develop interventions against the COVID-19 pandemic. We propose a new approach for drug repurposing involving two-stage prediction and machine learning. First, diseases are clustered by gene expression on the premise that similar patterns of altered gene expression imply critical pathways shared in different disease conditions. Next, drug efficacy is assessed by the reversibility of abnormal gene expression, and results are clustered to identify repurposing targets. To cluster similar diseases, gene expression data from 262 cases of 31 diseases and 268 controls were analyzed by Uniform Manifold Approximation and Projection for Dimension Reduction followed by k -means to optimize the number of clusters. For evaluation, we examined disease-specific gene expression data for inclusion, body myositis, polymyositis, and dermatomyositis (DM), and used LINCS L1000 characteristic direction signatures search engine (L1000CDS 2 ) to obtain lists of small-molecule compounds that reversed the expression patterns of these specifically altered genes as candidates for drug repurposing. Finally, the functions of affected genes were analyzed by Gene Set Enrichment Analysis to examine consistency with expected drug efficacy. Consequently, we found disease-specific gene expression, and importantly, identified 20 drugs such as BMS-387032, phorbol-12-myristate-13-acetate, mitoxantrone, alvocidib, and vorinostat as candidates for repurposing. These were previously noted to be effective against two of the three diseases, and have a high probability of being effective against the other. That is, inclusion body myositis and DM. The two-stage prediction approach to drug repurposing presented here offers innovation to inform future drug discovery and clinical trials in a variety of human diseases.

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Artificial intelligence in drug repurposing for rare diseases: a mini-review

Application of artificial intelligence and machine learning in drug repurposing

Drug repurposing for rare: progress and opportunities for the rare disease community

Artificial intelligence, machine learning, and drug repurposing in cancer

Drug Repurposing: A Leading Strategy for New Threats and Targets

Application of Artificial Intelligence in Drug Repurposing: A mini-review

Drug discovery and development: the role of artificial intelligence in drug repurposing

A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene Expression

Artificial intelligence in COVID-19 drug repurposing

Drug repurposing for personalized medicine

Knowledge Graphs and Explainable AI for Drug Repurposing on Rare Diseases

Drug repurposing—an emerging strategy in cancer therapeutics

Recent advances in drug repurposing using machine learning

Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics

Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases

Accelerating Complex Disease Treatment through Network Medicine and GenAI: A Case Study on Drug Repurposing for Breast Cancer

Drug repositioning for orphan diseases.

Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation

Drug repurposing: progress, challenges and recommendations